Trials / Terminated
TerminatedNCT00309517
Randomized Study on Neoadjuvant Radio-Chemotherapy in Rectal Carcinoma Dukes B and C
A Prospectively Randomized Study on Neoadjuvant Radio-Chemotherapy in Patients With Operated Rectal Carcinoma Dukes B and C (pT2, pN1-3; pT3-4, pN0-3; M0.
- Status
- Terminated
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 700 (planned)
- Sponsor
- Austrian Breast & Colorectal Cancer Study Group · Network
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This clinical investigation examined the influence of preoperative radiotherapy in combination with postoperative 5-fluorouracil + leucovorin chemotherapy vs. 5-fluorouracil + leucovorin + MAb 17-1A chemo-immunotherapy on patients' local recurrence rate and overall survival time following surgery for rectal carcinoma Dukes B or C (T2-4, N0-3, M0).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fluourouracil | |
| DRUG | Leucovorin | |
| DRUG | MAb 17-1A |
Timeline
- Start date
- 1997-07-01
- First posted
- 2006-04-03
- Last updated
- 2006-04-03
Locations
8 sites across 1 country: Austria
Source: ClinicalTrials.gov record NCT00309517. Inclusion in this directory is not an endorsement.